This journal is an international medium directed towards the needs of academic, clinical, government and industrial analysis by publishing original research reports and critical reviews on pharmaceutical and biomedical analysis. It covers the interdisciplinary aspects of analysis in the pharmaceutical, biomedical and clinical sciences, including developments in analytical methodology, instrumentation, computation and interpretation. Submissions on novel applications focusing on drug purity and stability studies, pharmacokinetics, therapeutic monitoring, metabolic profiling; drug-related aspects of analytical biochemistry and forensic toxicology; quality assurance in the pharmaceutical industry are also welcome.

Studies from areas of well established and poorly selective methods, such as UV-VIS spectrophotometry (including derivative and multi-wavelength measurements), basic electroanalytical (potentiometric, polarographic and voltammetric) methods, fluorimetry, flow-injection analysis, etc. are accepted for publication in exceptional cases only, if a unique and substantial advantage over presently known systems is demonstrated. The same applies to the assay of simple drug formulations by any kind of methods and the determination of drugs in biological samples based merely on spiked samples. Drug purity/stability studies should contain information on the structure elucidation of the impurities/degradants.

Papers dealing with the analytical aspects of traditional folk medicines are acceptable if the results are expected to attract the interest of readers also outside the area of origin, i.e. they have a focus on innovative analytical approaches. Regional differences in the phytochemical content of traditional folk medicine will not be considered. Manuscripts reporting on the analysis of novel phytochemicals will only be considered if their biological activity has been previously published in an international medium. Pharmacokinetic studies of traditional folk medicine will only be considered if only the identified components have been demonstrated to be solely responsible for the pharmacological activity.

Bioanalytical papers (pharmacokinetic, bioequivalence, protein and DNA binding studies) are accepted if the focus is on innovative analytical methodology. Manuscripts describing the pharmacokinetic profile of a single compound will not be considered for review. Pharmacokinetic studies will only be considered if they offer new profiles of a drug(s) and its metabolite(s) or new understandings of the mechanisms in drug disposition or response of existing drugs. Analytical studies on new investigational drugs that are currently in the preclinical phase are only acceptable if their pharmacological activity is well documented in an international medium.

Human subjects research must provide ethical approval and should include the name of the approving committee and the name of the institution and reference number where approval was granted. Animal studies must be approved from their Institutions Animal Care and Use Committee or any equivalent ethics committee accompanied by the reference number. For blood sampling procedures in rodents, retro-orbital bleeding will only be considered if a minimum of 7 days is allowed between repeat sampling. Furthermore, in the evaluation of the manuscript the editors reserve the right to determine whether the animal experimental technique is appropriate.

In determining the suitability of submitted articles for publication, particular scrutiny will be placed on the degree of novelty and significance of the research and the extent to which it adds to existing knowledge in pharmaceutical and biomedical analysis. In all submissions to the journal, authors must address the question of how their proposed methodology compares with previously reported methods. A substantial body of work cannot be fractionated into different shorter papers.

Reviews
Full Length Research Papers
Short Communications

Editors
Coral Barbas
University San Pablo CEU Center for Metabolomics and Bioanalysis, Boadilla del Monte, Spain Email Coral Barbas
Bezhan Chankvetadze
Ivane Javakhishvili Tbilisi State University, T'bilisi, Georgia Email Bezhan ChankvetadzeSubmission address: Sepaserve GmbH, Johann-Krane-Weg 42, 48149 Münster, Germany
Sandra Furlanetto
University of Florence, Firenze, Italy Email Sandra Furlanetto
Markus Ganzera
University of Innsbruck, Innsbruck, Austria Email Markus Ganzera
Jun Haginaka
Mukogawa Women's University School of Pharmacy and Pharmaceutical Sciences Graduate School of Pharmacy and Pharmaceutical Sciences, Nishinomiya, Japan Email Jun Haginaka
Shaoping Li
University of Macau, Taipa, Macao Email Shaoping Li
Ruin Moaddel
National Institute on Aging, Bethesda, Maryland, United States Email Ruin Moaddel
Sibel Ozkan
Ankara University, Ankara, Turkey Email Sibel Ozkan
Jean-Luc Veuthey
University of Geneva, Geneva, Switzerland Email Jean-Luc Veuthey
Editorial Advisory Board
Steven Baertschi
Eli Lilly and Company, Indianapolis, Indiana, United States Email Steven Baertschi
Carlo Bertucci
University Hospital of Bologna Sant'Orsola-Malpighi Polyclinic, Bologna, Italy Email Carlo Bertucci
Françoise Bressolle
University of Montpellier, Montpellier, France Email Françoise Bressolle
Francesco Busardò
Polytechnic University of Marche, Ancona, Italy Email Francesco Busardò
Lukasz Ciesla
University of Alabama, Tuscaloosa, Alabama, United States Email Lukasz Ciesla
Salvatore Fanali
University of Verona, Verona, Italy Email Salvatore Fanali
Szabolcs Fekete
Pharmacy College Geneva-Lausanne, Geneva, Switzerland Email Szabolcs Fekete
Antonia Garcia
San Pablo CEU University, Boadilla, Spain Email Antonia Garcia
Sándor Görög
Gedeon Richter Nyrt, Budapest, Hungary Email Sándor Görög
Roberto Gotti
University of Bologna, Bologna, Italy Email Roberto Gotti
Kenji Hamase
Kyushu University, Fukuoka, Japan Email Kenji Hamase
Brian L. He
Bristol-Myers Squibb Research New Brunswick, New Brunswick, New Jersey, United States Email Brian L. He
Tatsuya Higashi
Tokyo University of Science - Noda Campus, Noda, Japan Email Tatsuya Higashi
Emily Hilder
University of Tasmania, Hobart, Australia Email Emily Hilder
Ulrike Holzgrabe
University of Würzburg, Wurzburg, Germany Email Ulrike Holzgrabe
Philippe Hubert
University of Liege, Liege, Belgium Email Philippe Hubert
Zhengjin Jiang
Jinan University, Guangzhou, China Email Zhengjin Jiang
Krzysztof Jozwiak
Medical University of Lublin, Lublin, Poland Email Krzysztof Jozwiak
Michał Markuszewski
Medical University of Gdansk, Gdansk, Poland Email Michał Markuszewski
Laura Mercolini
University of Bologna, Bologna, Italy Email Laura Mercolini
Reinhard H.H. Neubert
Martin Luther University Halle Wittenberg, Halle, Germany Email Reinhard H.H. Neubert
Regina Oliveira
Federal University of Sao Carlos, Sao Carlos, Brazil Email Regina Oliveira
Bernard Olsen
Eli Lilly and Company, Indianapolis, Indiana, United States Email Bernard Olsen
Serena Orlandini
University of Florence, Firenze, Italy Email Serena Orlandini
Federica Pellati
University of Modena and Reggio Emilia, Modena, Italy Email Federica Pellati
Karen Phinney
National Institute of Standards and Technology, Gaithersburg, Maryland, United StatesEmail Karen Phinney
Simona Pichini
National Institute of Health, Roma, Italy Email Simona Pichini
Sergio Pinzauti
University of Florence, Firenze, Italy Email Sergio Pinzauti
Serge Rudaz
Pharmacy College Geneva-Lausanne, Geneva, Switzerland Email Serge Rudaz
Gerhard K.E. Scriba
Friedrich Schiller University Jena, Jena, Germany Email Gerhard K.E. Scriba
Kazutake Shimada
Kanazawa University, Japan
Saranjit Singh
National Inst. of Pharma. Education & Research, Dept. of Pharmaceutical Analysis, Punjab, India Email Saranjit Singh
Shigeo Suzuki
Kindai University, Osaka, Japan Email Shigeo Suzuki
Eva Szökö
Semmelweis University of Medicine, Budapest, Hungary Email Eva Szökö
Tung-Hu Tsai
National Yang Ming University Department of Chemical Engineering, Miaoli, Taiwan Email Tung-Hu Tsai
Ann Van Schepdael
KU Leuven Association, Leuven, Belgium Email Ann Van Schepdael
Yvan Vander Heyden
VUB University, Brussel, Belgium Email Yvan Vander Heyden
Bastiaan Venhuis
National Institute of Public Health and the Environment, Bilthoven, Netherlands Email Bastiaan Venhuis
Ian D. Wilson
Imperial College London, London, United Kingdom Email Ian D. Wilson
Guowang Xu
Dalian Institute of Chemical Physics, Dalian, China Email Guowang Xu
Min Ye
Peking University, Beijing, China Email Min Ye